December 15, 2022

ACEP-ONDCP Webinar on Naloxone

Poisoning or drug overdose recently surpassed motor vehicle crash as the number one cause of injury-related death in the United States. There has been a rapid increase in fatal overdose since the mid-1990’s which is largely attributable to the increase in prescribed opioids as well as prescription opioid misuse and abuse. Additionally, heroin-related overdose deaths are also increasing and many new-initiates of heroin report first misusing prescription opioids. Along with this rise in fatal overdose, there has also been an increase in opioid related ED visits secondary to non-fatal overdose or misuse.

The distribution of naloxone, an opioid agonist, has been associated with a with a decline in fatal overdoses in population based studies, has been long used by community-based/public health programs and is increasingly used in medical settings including primary care and emergency departments. This webinar discusses recent research and programs on provision of take-home naloxone to ED patients at risk for opioid overdose, as part of a strategy to reduce opioid related harms and substance abuse. Lastly, it highlights a successful take-home Naloxone program to discuss the real-world application and implementation of a take-home Naloxone program. 

Panelists Include: Michael Botticelli – Acting Director of the White House ONDCP; Megan Ranney MD MPH FACEP – Assistant Professor of Emergency Medicine and the Department of Health Services Policy and Practice at Brown University; Lauren Whiteside MD MS – Instructor in the Division of Emergency Medicine at the University of Washington; Caleb Banta-Green PhD MPH MSW – Research Scientist; Ed Bernstein MD – Professor of Emergency Medicine and Director of the Brief Negotiated Interview & Active Referral to Treatment (BNI-ART) Institute at Boston University Medical Center (BUMC). 

Download PDF

[ Feedback → ]